Deming, Dustin A.
Cavalcante, Ludmila L.
Lubner, Sam J.
Mulkerin, Daniel L.
LoConte, Noelle K.
Eickhoff, Jens C.
Kolesar, Jill M.
Fioravanti, Suzanne
Greten, Tim F.
Compton, Kathryn
Doyle, Austin G.
Wilding, George
Duffy, Austin
Liu, Glenn
Funding for this research was provided by:
National Cancer Institute (U01 CA062491)
National Cancer Institute (P30 CA014520)
Article History
Received: 30 October 2015
Accepted: 8 December 2015
First Online: 14 December 2015
Compliance with ethical standards
:
: This study was supported by grants from the National Cancer Institute: U01 CA062491to Glenn Liu and P30 CA014520 to University of Wisconsin–Madison Carbone Cancer Center. We gratefully acknowledge the support of AstraZeneca who provided the selumetinib for this clinical trial.
: The authors declare that they have no conflict of interest.